The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Open accessAbstract
Inflammation predisposes to the development of cancer and promotes all stages of tumorigenesis. Cancer cells, as well as surrounding stromal and inflammatory cells, engage in well-orchestrated reciprocal interactions to form an inflammatory tumor microenvironment (TME). Cells within the TME are highly plastic, continuously changing their phenotypic and functional characteristics. Here, we review the origins of inflammation in tumors, and the mechanisms whereby inflammation drives tumor initiation, growth, progression, and metastasis. We discuss how tumor-promoting inflammation closely resembles inflammatory processes typically found during development, immunity, maintenance of tissue homeostasis, or tissue repair and illuminate the distinctions between tissue-protective and pro-tumorigenic inflammation, including spatiotemporal considerations. Defining the cornerstone rules of engagement governing molecular and cellular mechanisms of tumor-promoting inflammation will be essential for further development of anti-cancer therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Self-citationGalluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 2×
“However, inducers of TEI in microbial-rich versus “sterile” tumors may be different (Hanahan and Coussens, 2012; Mantovani et al., 2008).”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,001
Fu, Y., Li, J., Cai, W., Huang, Y., Liu, X., Ma, Z., Tang, Z., Bian, X., Zheng, J., Jiang, J., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.018 · Cited by 48
Zhang, W., Zhu, Y., Liu, H., Zhang, Y., Liu, H., Adegboro, A. A., Dang, R., Dai, L., Wanggou, S., & Li, X. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00570-5 · Cited by 49
Wang, R., Zhao, Y., Zhou, L., Lin, F., Wan, M., Gan, A., Wu, B., Yan, T., & Jia, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155581 · Cited by 48
Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression
Park, J. H., Mortaja, M., Son, H. G., Zhao, X., Sloat, L. M., Azin, M., Wang, J., Collier, M. R., Tummala, K. S., Mandinova, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48441-8 · Cited by 48
Clonal hematopoiesis, aging, and cardiovascular diseases
Pardali, E., Dimmeler, S., Zeiher, A. M., & Rieger, M. A. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.006 · Cited by 50
Natural Compounds with Potential to Modulate Cancer Therapies and Self-Reactive Immune Cells
Moody, R., Wilson, K., Jaworowski, A., & Plebanski, M. (2020) · Cancers · doi:10.3390/cancers12030673 · Cited by 52
Cancer risk in patients with psoriasis: should we be paying more attention?
Loft, N., Vaengebjerg, S., & Skov, L. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1754194 · Cited by 49
Lin, Y., Cheng, L., Liu, Y., Wang, Y., Wang, Q., Wang, H., Shi, G., Li, J., Wang, Q., Yang, Q., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0297-3 · Cited by 49
Hu, K., Sjölander, A., Lu, D., Walker, A. K., Sloan, E. K., Fall, K., Valdimarsdóttir, U. A., Hall, P. N., Smedby, K. E. E., & Fang, F. (2020) · BMC Medicine · doi:10.1186/s12916-020-01709-4 · Cited by 51
Metabolic Cancer-Macrophage Crosstalk in the Tumor Microenvironment
de Goede, K. E., Driessen, A. J. M., & den Bossche, J. V. (2020) · Biology · doi:10.3390/biology9110380 · Cited by 49
Huynh, D. T. N., Jin, Y., Myung, C., & Heo, K. (2021) · Cancers · doi:10.3390/cancers13081892 · Cited by 49
Asslih, S., Damri, O., & Agam, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116138 · Cited by 51
Microbiome in cancer progression and therapy
Andreeva, N., Gabbasova, R. R., & Grivennikov, S. I. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.09.001 · Cited by 48
Self-citationAngiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth
Menzel, L., Höpken, U. E., & Rehm, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.591741 · Cited by 50
Colorectal Cancer Detected by Machine Learning Models Using Conventional Laboratory Test Data
Li, H., Lin, J.-M., Xiao, Y., Zheng, W., Zhao, L., Yang, X., Zhong, M., & Liu, H. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211058352 · Cited by 47
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer
Nolan, E., & Malanchi, I. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2022.101598 · Cited by 49
Al-Kushi, A. G., Elazab, S. T., Abdelfattah‐Hassan, A., Mahfouz, H., Salem, G. A., Sheraiba, N. I., Mohamed, E., Attia, M. S., El‐Shetry, E. S., Saleh, A. A., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061183 · Cited by 47
The research progress in the interaction between Candida albicans and cancers
Yu, D., & Liu, Z. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.988734 · Cited by 52
Zhou, R. W., Xu, J., Martin, T. C., Zachem, A. L., He, C., Ozturk, S., Demircioğlu, D., Bansal, A., Trotta, A. P., Giotti, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33377-8 · Cited by 49
Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment
Zhao, Y., Tan, H., Zhang, J., Pan, B., Wang, N., Chen, T., Shi, Y., & Wang, Z. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s432279 · Cited by 47
Mao, X., Wu, S., Huang, D., & Li, C. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.006 · Cited by 53
Gharib, E., & Robichaud, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179463 · Cited by 55
Chu, T., Zhu, G., Tang, Z., Qu, W., Yang, R., Pan, H., Wáng, Y., Tian, R., Chen, L., Guan, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62132-y · Cited by 55
Immunomodulatory Effect of Microglia-Released Cytokines in Gliomas
Lanza, M., Casili, G., Campolo, M., Paterniti, I., Colarossi, C., Mare, M., Giuffrida, R., Caffo, M., Esposito, E., & Cuzzocrea, S. (2021) · Brain Sciences · doi:10.3390/brainsci11040466 · Cited by 50
TNFα and Immune Checkpoint Inhibition: Friend or Foe for Lung Cancer?
Benoot, T., Piccioni, E., Ridder, K. D., & Goyvaerts, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168691 · Cited by 48
Han, C., Meng, G.-X., Ding, Z., Dong, Z., Chen, Z., Hong, J., Yan, L., Liu, H., Tian, B., Yang, L.-S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.827788 · Cited by 46
Nissen, E. R., Neumann, H., Knutzen, S. M., Henriksen, E. N., Amidi, A., Johansen, C., von Heymann, A., Christiansen, P., & Zachariae, R. (2024) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkae041 · Cited by 46
Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers
Ni, Y., Low, J. T., Silke, J., & O’Reilly, L. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835997 · Cited by 47
Han, W., Du, C., Yingguo, Z., Ran, L., Wang, Y., Xiong, J., Wu, Y., Lan, Q., Wang, Y., Wang, L., et al. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.03.006 · Cited by 46
Inflammatory effects of hexavalent chromium in the lung: A comprehensive review
Kouokam, J. C., Meaza, I., & Wise, J. P. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116265 · Cited by 53
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches
Conti, V., Corbi, G., Sabbatino, F., Pascale, D. D., Sellitto, C., Stefanelli, B., Bertini, N., Simone, M. D., Liguori, L., Paola, I. D., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13020334 · Cited by 46
Macrophage‐Biomimetic Nanoplatform‐Based Therapy for Inflammation‐Associated Diseases
Qu, Y., Chu, B., Li, J., Deng, H., Niu, T., & Qian, Z. (2023) · Small Methods · doi:10.1002/smtd.202301178 · Cited by 46
Zhang, Y., Lin, X., Xia, L., Xiong, S., Xia, B., Xie, J., Lin, Y., Lin, L., & Wu, P. (2024) · Molecules · doi:10.3390/molecules29163852 · Cited by 47
Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies
Yang, J., Zhou, F., Luo, X., Fang, Y., Wang, X., Liu, X., Xiao, R., Jiang, D., Tang, Y., Yang, G., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02366-3 · Cited by 56
SOX18 promotes gastric cancer metastasis through transactivating MCAM and CCL7
Chen, J., Dang, Y., Feng, W., Qiao, C., Liu, D., Zhang, T., Wang, Y., Tian, D., Fan, D., Nie, Y., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1378-1 · Cited by 46
B cell heterogeneity, plasticity, and functional diversity in cancer microenvironments
Yuan, W., Huang, C.-X., Xiao, C., Chen, D., Shan, H., He, H., & Kuang, D. (2021) · Oncogene · doi:10.1038/s41388-021-01918-y · Cited by 46
Gossip in the gut: Quorum sensing, a new player in the host-microbiota interactions
Coquant, G., Aguanno, D., Pham, S., Grellier, N., Thenet, S., Carrière, V., Grill, J.-P., & Seksik, P. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i42.7247 · Cited by 47
Lai, C., Yeh, K., Liu, B., Chang, T.-M., Chang, C.-H., Liao, Y.-F., Liu, Y., & Her, G. M. (2021) · Cancers · doi:10.3390/cancers13215565 · Cited by 45
Impact of immune cells on the hallmarks of cancer: A literature review
Costa, A. C., Santos, J., da Costa, R. M. G., & Medeiros, R. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103541 · Cited by 48
Wang, J., Chen, Y., Kee, K., Wang, C., Tsai, M., Kuo, Y., Hung, C., Li, W.-F., Li, W., & Chen, Y. (2022) · Cancers · doi:10.3390/cancers14020343 · Cited by 46
Positron emission tomography molecular imaging‐based cancer phenotyping
Jin, C., Luo, X., Li, X., Zhou, R., Zhong, Y., Xu, Z., Cui, C., Xing, X., Zhang, H., & Tian, M. (2022) · Cancer · doi:10.1002/cncr.34228 · Cited by 45
Zhou, X., Afzal, S., Wohlmuth, H., Münch, G. W., Leach, D. N., Low, M., & Li, C. G. (2022) · Molecules · doi:10.3390/molecules27123877 · Cited by 45
Neutrophils: New Critical Regulators of Glioma
Wang, G., Wang, J., Niu, C., Zhao, Y., & Wu, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.927233 · Cited by 46
Sun, K., Wu, L., Wang, S., & Deng, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.949332 · Cited by 46
Inhibition of Cancer Development by Natural Plant Polyphenols: Molecular Mechanisms
Lyubitelev, A. V., & Studitsky, V. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310663 · Cited by 53
Clinical utility of the pan-immune-inflammation value in breast cancer patients
Qi, X., Qiao, B., Song, T., Huang, D., Zhang, H., Liu, Y., Jin, Q., Yang, M. W., & Liu, D. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1223786 · Cited by 47
Mechanotransduction in response to ECM stiffening impairs cGAS immune signaling in tumor cells
Liu, Y., Yao, X., Zhao, Y., Fang, D., Shi, L., Yang, L., Song, G., Cai, K., Li, L., Deng, Q., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113213 · Cited by 48
Nerve Growth Factor and the Role of Inflammation in Tumor Development
Ferraguti, G., Terracina, S. A., Tarani, L., Fanfarillo, F., Allushi, S., Caronti, B., Tirassa, P., Polimeni, A., Lucarelli, M., Cavalcanti, L., et al. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46020062 · Cited by 45
The relationship between pancreatic cancer and type 2 diabetes: cause and consequence
Li, Y., Bian, X., Wei, S., He, M., & Yang, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s211972 · Cited by 49
Kuang, J., Huang, Y., Hu, J., Yu, J., Zhou, Q., & Liu, D. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104212 · Cited by 45
Ligands stimulating antitumour immunity as the next G-quadruplex challenge
Miglietta, G., Marinello, J., Russo, M., & Capranico, G. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01649-y · Cited by 44
“Unfortunately, many tumours do not respond to them or become unresponsive at relapse [95], highlighting”
BackgroundEP2 Antagonists (2011–2021): A Decade’s Journey from Discovery to Therapeutics
Sluter, M. N., Hou, R., Li, L., Yasmen, N., Yu, Y., Liu, J., & Jiang, J. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00816 · Cited by 44
Emerging roles of circular RNAs in liver cancer
Louis, C., Leclerc, D., & Coulouarn, C. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100413 · Cited by 46
Pan, Z., Xie, X., Chen, Y., Pan, S., Wu, Z., Yang, C., Liang, J., Zhang, M., Wang, Q., Chen, J., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154454 · Cited by 44
Feline Oncogenomics: What Do We Know about the Genetics of Cancer in Domestic Cats?
Ludwig, L., Dobromylskyj, M., Wood, G. A., & van der Weyden, L. (2022) · Veterinary Sciences · doi:10.3390/vetsci9100547 · Cited by 46
CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
Yu, X., Chen, Y., Cui, L., Yang, K., Wang, X., Lei, L., Zhang, Y., Kong, X., Lao, W., Li, Z., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1052917 · Cited by 44
Yanghe decoction inhibits inflammation-induced lung metastasis of colorectal cancer
Zhang, L., Liu, S., Ding, K., Zeng, B., Li, B., Zhou, J., Li, J., Wang, J., Su, X., & Sun, R. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119257 · Cited by 44
Wang, K., Li, K., Zhang, Z., Zeng, X., Wu, Z., Zhang, B., Pan, Y., Lau, L. Y., Zhao, Z., & Chen, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-15309-w · Cited by 45
Tenuta, M., Gelibter, A. J., Pandozzi, C., Sirgiovanni, G., Campolo, F., Venneri, M. A., Caponnetto, S., Cortesi, E., Marchetti, P., Isidori, A. M., et al. (2021) · Cancers · doi:10.3390/cancers13246355 · Cited by 44
Lamin A/C and the Immune System: One Intermediate Filament, Many Faces
Saéz, Á., Herrero‐Fernández, B., Gómez-Bris, R., Somovilla-Crespo, B., Rius, C., & González, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176109 · Cited by 43
Interleukin‐25: New perspective and state‐of‐the‐art in cancer prognosis and treatment approaches
Shabgah, A. G., Amir, A., Gardanova, Z. R., Zekiy, A. O., Thangavelu, L. P., Nik, M. E., Ahmadi, M., & Navashenaq, J. G. (2021) · Cancer Medicine · doi:10.1002/cam4.4060 · Cited by 43
Zhang, J., Feng, Y., Yang, X., Yang, L., Wu, Y., Yuan, L., Li, T.-Z., Hu, H., Li, X., Huang, H., et al. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac049 · Cited by 43
The role of exercise in obesity-related cancers: Current evidence and biological mechanisms
Larson, E. A., Dalamaga, Μ., & Magkos, F. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.02.008 · Cited by 43
Fagbohun, O. F., Gillies, C. R., Murphy, K., & Rupasinghe, H. P. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076092 · Cited by 48
Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota
Li, J., Ji, Y., Chen, N., Dai, L., & Deng, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01139-8 · Cited by 49
Pun, F. W., Leung, G. H. D., Leung, H.-W., Rice, J., Schmauck‐Medina, T., Lautrup, S., Long, X., Liu, B. H. M., Wong, C. W., Ozerov, I. V., et al. (2023) · Aging Cell · doi:10.1111/acel.14017 · Cited by 44
Hydrogels to engineer tumor microenvironments in vitro
Fernando, K., Kwang, L. G., Lim, J. T. C., & Fong, E. L. S. (2021) · Biomaterials Science · doi:10.1039/d0bm01943g · Cited by 44
Nucleic Acid Immunity and DNA Damage Response: New Friends and Old Foes
Taffoni, C., Steer, A., Marines, J., Chamma, H., Vila, I. K., & Laguette, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660560 · Cited by 39
Senescence and Immunoregulation in the Tumor Microenvironment
Ruhland, M. K., & Alspach, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.754069 · Cited by 45
Neuromodulation Applied to Diseases: The Case of HRV Biofeedback
Gitler, A., Vanacker, L., Couck, M., Leeuw, I. D., & Gidron, Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195927 · Cited by 45
The association of physician empathy with cancer patient outcomes: A meta‐analysis
Lelorain, S., Gehenne, L., Christophe, V., & Duprez, C. (2023) · Psycho-Oncology · doi:10.1002/pon.6108 · Cited by 42
Morgan, D., Berggren, K. L., Spiess, C., Smith, H. M., Tejwani, A., Weir, S. J., Lominska, C. E., Thomas, S. M., & Gan, G. N. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23348 · Cited by 42
The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma
Gu, Y., Guo, Y., Gao, N., Fang, Y., Xu, C., Hu, G., Guo, M., Ma, Y., Zhang, Y., Zhou, J., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02264-3 · Cited by 43
Entsie, P., Kang, Y., Amoafo, E. B., Schöneberg, T., & Liverani, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076709 · Cited by 45
Fan, N., Fusco, J. L., & Rosenberg, D. W. (2023) · Antioxidants · doi:10.3390/antiox12050982 · Cited by 44
Acidosis-related pain and its receptors as targets for chronic pain
Hung, C., Chin, Y., Fong, Y.-O., Lee, C., Han, D., Lin, J.-H., Sun, W., & Chen, C. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108444 · Cited by 43
Katsi, V. K., Papakonstantinou, I. P., & Tsioufis, K. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411786 · Cited by 43
Genomic instability as a driver and suppressor of anti-tumor immunity
Requesens, M., Foijer, F., Nijman, H. W., & de Bruyn, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1462496 · Cited by 45
The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone
Göbel, A., Dell'Endice, S., Jaschke, N., Pählig, S., Shahid, A., Hofbauer, L. C., & Rachner, T. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105078 · Cited by 45
Sleep Disruption and Cancer: Chicken or the Egg?
Berisha, A., Shutkind, K., & Borniger, J. C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.856235 · Cited by 44
Dey, P., & Chaudhuri, S. R. (2022) · Biology · doi:10.3390/biology11050757 · Cited by 45
Al‐Shalabi, E., Abusulieh, S., Hammad, A. M., & Sunoqrot, S. (2022) · Biomaterials Science · doi:10.1039/d2bm00309k · Cited by 45
The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 64
Key promoters of tumor hallmarks
Mortezaee, K., & Majidpoor, J. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-02074-9 · Cited by 42
Tang, D., Zhang, D., Heng, Y., Zhu, X.-K., Lin, H.-Q., Zhou, J., Tao, L., & Lu, L.-M. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s347777 · Cited by 42
Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis
Bi, Q., Wu, J., Qiu, X., Zhang, J., Sun, Z., & Wang, W. (2022) · Journal of Immunology Research · doi:10.1155/2022/3128933 · Cited by 47
Naseer, F., Ahmed, M., Majid, A., Kamal, W., & Phull, A. R. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.06.014 · Cited by 42
The oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammation
Yu, L., Maishi, N., Akahori, E., Hasebe, A., Takeda, R., Matsuda, A., Hida, Y., Nam, J., Onodera, Y., Kitagawa, Y., et al. (2022) · Cancer Science · doi:10.1111/cas.15538 · Cited by 41
Therapeutic Nanocarriers Inhibit Chemotherapy‐Induced Breast Cancer Metastasis
Li, T., Akinade, T., Zhou, J., Wang, H., Tong, Q., He, S., Rinebold, E., Salazar, L. E. V., Bhansali, D., Zhong, Y., et al. (2022) · Advanced Science · doi:10.1002/advs.202203949 · Cited by 40
You, Y., Chen, X., Chen, X., Li, H., Zhou, R., Zhou, J., Chen, M., Peng, B., Ji, S., Kwan, H. Y., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116358 · Cited by 41
Mann, V., Sundaresan, A., & Shishodia, S. (2024) · Biology · doi:10.3390/biology13040241 · Cited by 46
Peng, Z., Fang, C., Tong, Z., Rao, Q.-F., Ren, Z., & Hu, K. (2024) · Current Genomics · doi:10.2174/0113892029300608240531111743 · Cited by 47
TAp73 represses NF-κB–mediated recruitment of tumor-associated macrophages in breast cancer
Wolfsberger, J., Sakil, H. A. M., Zhou, L., van Bree, N. F. H. N., Baldisseri, E., Ferreira, S. D. S., Zubillaga, V., Stantic, M., Fritz, N., Hartman, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017089118 · Cited by 40
Down-regulation of A20 promotes immune escape of lung adenocarcinomas
Breitenecker, K., Homolya, M., Luca, A. C., Lang, V., Trenk, C., Petroczi, G., Mohrherr, J., Horvath, J., Moritsch, S., Haas, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc3911 · Cited by 42
O-GlcNAcylation and Its Role in Cancer-Associated Inflammation
Ouyang, M., Yu, C., Deng, X., Zhang, Y., Zhang, X., & Duan, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.861559 · Cited by 43
The unique role of innate lymphoid cells in cancer and the hepatic microenvironment
Curio, S., & Belz, G. T. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00901-1 · Cited by 41
FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA
Gan, X., Dai, Z., Ge, C.-M., Yin, H.-Z., Wang, Y., Tan, J., Sun, S., Zhou, W., Yuan, S., & Yang, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.989353 · Cited by 40
Age acquired skewed X chromosome inactivation is associated with adverse health outcomes in humans
Roberts, A. L., Morea, A., Amar, A., Zito, A., Moustafa, J. S. E.-S., Tomlinson, M., Bowyer, R. C. E., Zhang, X., Christiansen, C., Costeira, R., et al. (2022) · eLife · doi:10.7554/elife.78263 · Cited by 44
Understanding and modeling nerve–cancer interactions
Le, T. T., & Oudin, M. J. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049729 · Cited by 41
Regulation of inflammation in cancer by dietary eicosanoids
Yang, H., Rothenberger, E., Zhao, T., Fan, W., Kelly, A. G., Attaya, A., Fan, D., Panigrahy, D., & Deng, J. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108455 · Cited by 42
Metadata
- Authors
- Greten, F. R., & Grivennikov, S. I.
- Affiliations
- Goethe University Frankfurt (DE)
- Fox Chase Cancer Center (US)
- Corresponding author
- Greten, Florian R.
- Grivennikov, Sergei I.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 51
- Issue
- 1
- Pages
- 27-41
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC6831096
- OpenAlex
- W2959497269
- Cited by
- 3,806
- References
- 178
- Citations by year
- 2026: 457 · 2025: 640 · 2024: 753 · 2023: 715 · 2022: 664 · 2021: 397 · 2020: 163 · 2019: 16
- FWCI
- 26.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (R01CA227629, CA218133)
- Pew Scholar in Biomedical Sciences
- US-Israel BSF
- NIH (P30 CA-006927)
- Georg-Speyer-Haus
- LOEWE Center Frankfurt Cancer Institute (III L 5 - 519/03/03.001 - (0015), FOR2438: Gr1916/11-1, SFB 815, 1177, 1292)
- German Federal Ministry of Health
- Ministry of Higher Education, Research and the Arts of the State of Hessen
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- tumor inflammation, tumor inflammatory microenvironment, carcinogenesis, tumor initiation, tumor progression, metastasis, tumor-stroma interactions, cellular plasticity, tissue homeostasis, tissue repair, cancer therapy
- MeSH terms
- Animals, Chronic Disease, Homeostasis, Humans, Infections, Inflammation, Neoplasms, Neovascularization, Pathologic, Wound Healing, Autoimmunity, Tumor Microenvironment, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review